Aurobindo to produce Gilead meds in HIV pool; Sanofi inaugurates Irish Genzyme expansion;

@FiercePharma: Merck persuaded an Australian appeals court to overturn a Vioxx damages award of $259,400 News | Follow @FiercePharma

> Aurobindo Pharma joined the Medicines Patent Pool for production of AIDS drugs, in a deal that would allow the Indian drugmaker to turn out a range of HIV fighters licensed to the pool by Gilead Sciences. Article

> Sanofi ($SNY) CEO Christopher Viehbacher and Irish officials inaugurated a €150 million expansion at the French drugmaker's Genzyme facility in Waterford, Ireland. News

> The Belgian drug ingredients and dental device company Arseus was approached about a takeover, local media says, but executives called the reports market speculation. Report

> Edgemont Pharmaceuticals won the FDA nod for its 60-mg dose of fluoxetine, the generic version of Eli Lilly's ($LLY) antidepressant Prozac. Story

> Analysts changed their ratings on Vertex Pharmaceuticals ($VRTX), with JMP Securities upgrading the stock to "outperform" and a $53 price target and Bank of America lowering its target to $55. Report

> Better HIV drugs and earlier diagnoses pushed patients' life expectancy up by 15 years between 1996 and 2008, a study found. News

> Fitch Ratings affirmed AstraZeneca's ($AZN) debt rating at AA- and called the company outlook "stable." Story

Biotech News

@FierceBiotech: Pfizer, Exonhit partner on Alzheimer's biomarkers. More | Follow @FierceBiotech

@ JohnCFierce: In their settlement deal--spelled out in an 8K--Onyx gets U.S. co-promo rights to regorafenib. | Follow @JohnCFierce

@RyanMFierce: I saw twitter action on this fertility startup OvaScience a while ago, but @scottkirsner is 1st to write an article Article | Follow @RyanMFierce

 @MaureenFierce: @LifeSciVC: E&Y says 44% of drugs in dev are for oncology. @dereklowe asks, is that too many, too few or just right? Article Follow @MaureenFierce

> Bayer settles Onyx spat with $160M payout, sales rights and royalties. Piece

Medical Device News

> Report: Cook stent meets safety, effectiveness goals. Item

Drug Delivery News

> Nano-therapy that cooks deadly brain tumors advances in Germany. More

> Unigene forms joint venture to develop oral peptide drugs with Nordic Bioscience. Story

> Zosano inks Asian deal worth $32.5M-plus for drug patch tech. Report

And Finally... Men taking daily Vitamin E supplements were more likely to get prostate cancer, a study found. Article

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.